Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M209,484Revenue $M49,605Net Margin (%)18.4Z-Score2.7
Enterprise Value $M210,394EPS $1.4Operating Margin %25.6F-Score6
P/E(ttm))24.0Cash Flow Per Share $3.5Pre-tax Margin (%)24.7Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %2.6Quick Ratio2.4Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %4.4Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %-13.3ROA % (ttm)5.3Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yY
Payout Ratio %74.0Shares Outstanding M6,129ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impact (%)down Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEJean-Marie Eveillard 2014-12-31 Add0.39$27.7 - $32.09
($30.23)
$ 34.1613%Add 3786.85%5,272,943
PFERichard Pzena 2014-12-31 Buy 0.36$27.7 - $32.09
($30.23)
$ 34.1613%New holding, 2170568 sh.2,170,568
PFEVanguard Health Care Fund 2014-12-31 Add0.32$27.7 - $32.09
($30.23)
$ 34.1613%Add 29.88%19,395,622
PFEIrving Kahn 2014-12-31 Reduce-0.49$27.7 - $32.09
($30.23)
$ 34.1613%Reduce -5.14%1,883,217
PFEMichael Price 2014-12-31 Sold Out -0.17$27.7 - $32.09
($30.26)
$ 34.1613%Sold Out0
PFERay Dalio 2014-12-31 Reduce-0.02$27.7 - $32.09
($30.23)
$ 34.1613%Reduce -28.43%211,208
PFEIrving Kahn 2014-09-30 Reduce-0.59$28.04 - $30.96
($29.58)
$ 34.1616%Reduce -6.56%1,985,161
PFEMichael Price 2014-09-30 Reduce-0.22$28.04 - $30.96
($29.58)
$ 34.1616%Reduce -56.02%47,100
PFEJean-Marie Eveillard 2014-09-30 Reduce-0.16$28.04 - $30.96
($29.58)
$ 34.1616%Reduce -94.11%135,661
PFERay Dalio 2014-09-30 Reduce-0.02$28.04 - $30.96
($29.58)
$ 34.1616%Reduce -24.91%295,108
PFEHOTCHKIS & WILEY 2014-09-30 Sold Out -0.01$28.04 - $30.96
($29.58)
$ 34.1616%Sold Out0
PFEVanguard Health Care Fund 2014-06-30 Add0.62$29.02 - $32.4
($30.05)
$ 34.1614%Add 105.23%14,934,022
PFEJoel Greenblatt 2014-06-30 Add0.27$29.02 - $32.4
($30.05)
$ 34.1614%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12$29.02 - $32.4
($30.05)
$ 34.1614%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06$29.02 - $32.4
($30.05)
$ 34.1614%Add 250.56%393,008
PFENWQ Managers 2014-06-30 Reduce-0.81$29.02 - $32.4
($30.05)
$ 34.1614%Reduce -31.07%6,363,006
PFEDodge & Cox 2014-06-30 Reduce-0.5$29.02 - $32.4
($30.05)
$ 34.1614%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47$29.02 - $32.4
($30.05)
$ 34.1614%Reduce -70.71%2,303,762
PFEJohn Hussman 2014-06-30 Sold Out -0.04$29.02 - $32.4
($30.05)
$ 34.1614%Sold Out0
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01$29.02 - $32.4
($30.05)
$ 34.1614%Reduce -33.68%128,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE Richard Pzena 2014-12-312,170,5680.040.36New Buy
PFE Jean-Marie Eveillard 2014-12-315,272,9430.090.4+3786.85%
PFE Vanguard Health Care Fund 2014-12-3119,395,6220.321.4+29.88%
PFE John Keeley 2014-12-3199,95900.06+2.69%
PFE James Barrow 2014-12-3162,760,1631.022.6+0.95%
PFE Robert Bruce 2014-12-31455,3320.013.9+0.74%
PFE Charles Brandes 2014-12-316,272,0970.12.8+0.24%
PFE NWQ Managers 2014-12-316,349,3770.12.4+0.17%
PFE Brian Rogers 2014-12-3112,737,1150.211.4
PFE Prem Watsa 2014-12-31235,00000.47
PFE Ruane Cunniff 2014-12-3110,96700
PFE Dodge & Cox 2014-12-3147,195,5730.771.4-0.86%
PFE Ken Fisher 2014-12-3131,196,4150.512-1.6%
PFE David Dreman 2014-12-3114,79200.04-1.65%
PFE Ronald Muhlenkamp 2014-12-3138,40900.24-2.76%
PFE Irving Kahn 2014-12-311,883,2170.0310.1-5.14%
PFE Mario Gabelli 2014-12-31951,5830.020.15-7.03%
PFE Joel Greenblatt 2014-12-311,420,9480.020.36-12.4%
PFE Ray Dalio 2014-12-31211,20800.05-28.43%
PFE Michael Price 2014-12-31000Sold Out
PFE Mark Hillman 2013-12-3123,98201.1
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$340.88view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.62-0.92view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.46-0.46view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.73-1.24view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.85-1.58view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.30view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.230.2view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.781.54view
MADDALUNA ANTHONY JExecutive Vice President 2014-12-08Sell6,500$327.19view
HILL CHARLES HExecutive Vice President 2014-11-10Sell8,285$30.1813.65view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    DE Mar 24 2015 
    Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
    A look at Jean-Marie Eveillard's investment in Pfizer Mar 17 2015 
    Top Pharma Stock Picks For March Mar 13 2015 
    Johnson & Johnson Unfazed By $25 Million Fine Mar 13 2015 
    AbbVie Strikes The Biggest Deal For Treatment Of Cancer Mar 10 2015 
    Pfizer Will Supply Drugs To UNICEF Mar 05 2015 
    Novartis Goes A Step Forward In Treating Lung Cancer Mar 02 2015 
    Lower GDP Estimate Weighs on U.S. Indexes Feb 28 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 


    More From Other Websites
    IPO Stock Watch: CAR-T Maker Cellectis Slips In Debut Mar 25 2015
    Merger momentum keeps on rolling with Heinz deal for Kraft Mar 25 2015
    Merger momentum keeps on rolling with Heinz deal for Kraft Mar 25 2015
    Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD):... Mar 25 2015
    Science, patients driving rare disease drug research surge Mar 25 2015
    Science, patients driving rare disease drug research surge Mar 25 2015
    Pfizer (PFE) Is The 'Chart of the Week' Mar 25 2015
    4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary Mar 25 2015
    Lpath (LPTN) Crumbles on Failure of Kidney Cancer Drug Trial - Analyst Blog Mar 25 2015
    The 5 Most Shorted NYSE Stocks in March Mar 25 2015
    Merck halts study in light of melanoma drug’s success Mar 24 2015
    Hottest dividend stocks of 2015 Mar 24 2015
    Foreign investors buy UK firms at fastest pace since 2007 Mar 24 2015
    Foreign investors buy UK firms at fastest pace since 2007 Mar 24 2015
    Faster FDA Spurs Cancer Breakthroughs Mar 24 2015
    Pfizer & Eli Lilly to Resume Phase III Study of Tanezumab - Analyst Blog Mar 24 2015
    Will pharma rally continue? Mar 24 2015
    Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts Mar 24 2015
    Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts Mar 24 2015
    Stocks turn positive on strong housing number Mar 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 9 months ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK